News

Inspire Fidelis Multi Factor ETF Achieves Significant Milestones

Inspire Fidelis Multi Factor ETF Achieves Significant Milestones

Inspire Fidelis Multi Factor ETF Achieves Major Milestones

Inspire Investing is excited to announce significant achievements for the Inspire Fidelis Multi Factor ETF (NYSE: FDLS). Recently, this innovative investment vehicle celebrated its third anniversary while exceeding $100 million in assets under management. This milestone was observed just after its anniversary, underscoring the increasing interest from investors in values-aligned investment options.

Investor Interest in Faith-Based Investments

Robert Netzly, CEO of Inspire Investing, commented, "FDLS reaching this milestone is more than just a number—it's a signal that investors are hungry for values-driven alternatives that don't compromise on performance or integrity. This achievement reflects the growing desire to invest with conviction, and we are grateful to serve investors who want their money to make a difference." This sentiment echoes the evolving investment landscape, where investors prioritize ethical and value-based solutions.

The Investment Strategy of FDLS

Launched in 2022, the Inspire Fidelis Multi Factor ETF offers investors a well-rounded equity portfolio that thoughtfully integrates momentum, value, and quality factors. All investments are screened for alignment with biblical values through Inspire's proprietary Inspire Impact Score™ methodology. This unique approach not only focuses on financial performance but also aligns with the ethical considerations of many investors.

Morningstar Recognition

FDLS has earned a 4-star Overall Morningstar Rating™, which evaluates funds based on risk-adjusted returns relative to similar funds. As of a recent date, it has ranked as one of the top performers in the mid-cap blend category, further solidifying its position among leading ETFs. Morningstar’s rating system is recognized for its rigor and provides investors with valuable insights.

Inspire’s Growing ETF Platform

Inspire Investing manages a robust lineup of faith-based investment solutions, with FDLS being one of its nine exchange-traded funds. The firm’s ETF platform has grown to manage over $2.1 billion in assets, contributing to a total of more than $3.5 billion across various investment solutions as of a recent evaluation date. This growth illustrates the increasing recognition of faith-based investing as a viable option for many investors.

Recognition and Achievements

Since its inception, Inspire Investing has received numerous accolades for its innovative approach. It has appeared in FA Magazine’s list of the Top 50 Fastest Growing Firms, as well as being recognized multiple times by The Financial Times for its rapid growth. Additionally, Inspire has made the Inc. 5000 list of fastest-growing private companies several years running, reaffirming its established presence in the investment industry.

Commitment to Charitable Initiatives

Inspire’s commitment extends beyond investment performance; through its Give50 Program, the firm donates 50% or more of its net corporate profits from management fees to support impactful ministry projects worldwide. This initiative underscores Inspire's mission to create positive change through investing, aligning financial growth with charitable contributions.

About Inspire Investing

Inspire Investing stands as the leading provider of faith-based ETFs globally. Its proprietary Inspire Impact Score™ methodology combines exclusionary screening with positive impact investing, firmly rooted in biblically responsible principles. This approach reflects the firm’s commitment to aligning investment strategies with deeply-held beliefs and values.

Whether considering its investment offerings or the broader economic impact, Inspire aims to meet the evolving needs of its clients who seek to invest in a manner that resonates with their values.

Frequently Asked Questions

What is the Inspire Fidelis Multi Factor ETF?

The Inspire Fidelis Multi Factor ETF (NYSE: FDLS) is an investment vehicle that offers exposure to a diversified portfolio of equities that align with biblical values.

How does the Inspire Impact Score work?

The Inspire Impact Score is a proprietary methodology used to screen investments based on their alignment with biblical principles, evaluating both performance and ethical considerations.

Why is FDLS considered a faith-based ETF?

FDLS is categorized as a faith-based ETF because it utilizes investment strategies aligned with biblical values, catering to investors seeking ethical investment alternatives.

What recent milestone did FDLS achieve?

FDLS recently celebrated its third anniversary and surpassed $100 million in assets under management, marking significant growth and investor interest.

What recognition has Inspire Investing received?

Inspire Investing has been recognized multiple times for its growth, including appearances on FA Magazine’s Top 50 Fastest Growing Firms list and the Financial Times’ rankings for rapidly growing companies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading